Watch AGL. Know when insiders buy.
One email the day a filing lands. Free.
AGL
agilon health, inc.
88.50
+2.02 +2.34%
USD · close Sep 4
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
23
FLAG · shorts 23
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $1.5BP/E —DIV YIELD —FCF YIELD -5.72%REV TTM $5.9B +0.3%NET INCOME −$232.2MNET CASH $72.2M52W 7.91 – 129.84SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $1.5B | +7.2% | — | $11.8M | $18M | — | 1.04 | −$57.3M | $3.4M | −$60.7M | Aug 5 |
| Q1 2026 · Mar 31 | $1.4B | −7.3% | — | $4M | $48.9M | +303.9% | 2.94 | $23.7M | $3.1M | $20.6M | May 6 |
| Q4 2025 · Dec 31derived | $1.6B | +3.1% | — | −$193.8M | −$188.9M | — | — | −$20.5M | $3M | −$23.5M | Feb 25 |
| Q3 2025 · Sep 30 | $1.4B | −1.1% | — | −$131.3M | −$110.2M | — | — | −$18.2M | $3.2M | −$21.3M | Nov 4 |
| Q2 2025 · Jun 30 | $1.4B | −5.9% | — | −$116M | −$104.4M | — | -6.31 | −$35.1M | $3.3M | −$38.3M | Aug 5 |
| Q1 2025 · Mar 31 | $1.5B | −4.5% | — | −$22.1M | $12.1M | — | 0.73 | −$32M | $3.8M | −$35.8M | May 6 |
| Q4 2024 · Dec 31derived | $1.5B | +44.2% | — | −$108.1M | −$105.8M | — | — | $16.4M | $3.3M | $13.2M | Feb 25 |
| Q3 2024 · Sep 30 | $1.5B | +27.6% | — | −$133.5M | −$117.6M | — | — | −$7.7M | $3.5M | −$11.2M | Nov 4 |
| Q2 2024 · Jun 30 | $1.5B | — | — | −$43.3M | −$30.7M | — | — | −$18.7M | $3.3M | −$22M | Aug 4 |
| Q1 2024 · Mar 31 | $1.6B | — | — | −$7.2M | −$6.1M | — | — | −$47.8M | $3.1M | −$50.9M | May 6 |
| Q4 2023 · Dec 31derived | $1.1B | — | — | −$164.3M | −$230.4M | — | — | −$61.2M | $3.9M | −$65.1M | Feb 25 |
| Q3 2023 · Sep 30 | $1.1B | — | — | −$39.3M | −$31.4M | — | — | −$13M | $4.1M | −$17.1M | Nov 7 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $5.9B | — | −$463.2M | −$391.3M | -6.6% | — | −$105.8M | $13.2M | −$119M | — | — |
| FY2024 · to Dec 31 | $6.1B | — | −$292.1M | −$260.2M | -4.3% | — | −$57.8M | $13.3M | −$71M | — | — |
| FY2023 · to Dec 31 | $4.3B | — | −$232.1M | −$262.6M | -6.1% | — | −$156.2M | $15.8M | −$172M | $200M | — |
| FY2022 · to Dec 31 | $2.4B | — | −$105.4M | −$106.6M | -4.5% | — | −$130.8M | $15.4M | −$146.2M | — | — |
| FY2021 · to Dec 31 | $1.5B | — | −$372.2M | −$406.5M | -26.7% | — | −$148.2M | $6.6M | −$154.7M | — | — |
| FY2020 · to Dec 31 | $1.2B | — | −$56.7M | −$60.1M | -4.9% | — | −$53.2M | $1.8M | −$55M | $6.7M | — |
Every number comes from agilon health, inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.